Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson’s disease patients

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2051-5960
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson’s disease patients ; volume:6 ; number:1 ; day:8 ; month:2 ; year:2018 ; pages:1-9 ; date:12.2018
Acta Neuropathologica Communications ; 6, Heft 1 (8.2.2018), 1-9, 12.2018

Keyword
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit

Creator
Recasens, Ariadna
Contributor
Carballo-Carbajal, Iria
Parent, Annabelle
Bové, Jordi
Gelpi, Ellen
Tolosa, Eduardo
Vila, Miquel
SpringerLink (Online service)

DOI
10.1186/s40478-018-0509-1
URN
urn:nbn:de:1111-201804157509
Rights
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:46 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Recasens, Ariadna
  • Carballo-Carbajal, Iria
  • Parent, Annabelle
  • Bové, Jordi
  • Gelpi, Ellen
  • Tolosa, Eduardo
  • Vila, Miquel
  • SpringerLink (Online service)

Other Objects (12)

Dermal α-synuclein oligomers and aggregates in Parkinson’s disease

Dermal α-synuclein oligomers and aggregates in Parkinson’s disease

Characterization of the pathogenic α-Synuclein Variant V15A in Parkinson´s disease

Characterization of the pathogenic α-Synuclein Variant V15A in Parkinson´s disease

Small soluble α-synuclein aggregates are the toxic species in Parkinson’s disease

Small soluble α-synuclein aggregates are the toxic species in Parkinson’s disease

Models of α-synuclein aggregation in Parkinson’s disease

Models of α-synuclein aggregation in Parkinson’s disease

α-Synuclein in parkinson's disease: pathogenic function and translation into animal models

α-Synuclein in parkinson's disease: pathogenic function and translation into animal models

Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease

Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease

Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease

Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease

Correction: Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease

Correction: Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease

Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease

Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease

Initiation and progression of α-synuclein pathology in Parkinson’s disease

Initiation and progression of α-synuclein pathology in Parkinson’s disease

GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease

GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease

Adenosine A1 receptor ligands bind to α-synuclein: implications for α-synuclein misfolding and α-synucleinopathy in Parkinson’s disease

Adenosine A1 receptor ligands bind to α-synuclein: implications for α-synuclein misfolding and α-synucleinopathy in Parkinson’s disease

Related objects